Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-02-17 @ 10:40 PM
Study NCT ID:
NCT02315534
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2014-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BBI608-251
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None